Navigation Links
Bernstein Liebhard LLP Notes Plaintiffs’ Opposition to Defense Motion in Federal Litigation of DePuy Pinnacle Lawsuit Claims
Date:6/24/2013

(PRWEB) June 24, 2013

Plaintiffs involved with federally-filed DePuy Pinnacle lawsuit claims are engaged in motion practice regarding expert testimony they argue is crucial to the lawsuits pending in the DePuy Pinnacle MDL, Bernstein Liebhard LLP reports.

According to court documents, the issue hinges on whether a particular expert will be able to testify at trial. Plaintiffs in DePuy Pinnacle lawsuits filed in the federal litigation established in the U.S. District Court, Northern District of Texas allege the all-metal version of the DePuy Pinnacle Hip Replacement System, which includes an Ultamet liner, caused them to suffer metallosis and other painful complications indicating early hip failure. (In re: DePuy Orthopaedics, Inc. Pinnacle Hip Implant Products Liability Litigation - MDL No. 2244)

“We are pleased to see DePuy Pinnacle hip replacement lawsuits moving forward in the federal litigation as we continue to hear from patients who allegedly experienced metallosis and other complications stemming from the all-metal version of the Pinnacle hip replacement,” says Bernstein Liebhard LLP, a nationwide law firm representing individuals affected by defective drugs and medical devices. The Firm is actively filing lawsuits in the federal litigation on behalf of patients allegedly injured by the artificial hip. Additionally, Bernstein Liebhard LLP partner, Jeffrey S. Grand is serving on the Plaintiffs’ Steering Committee in the litigation.

DePuy Pinnacle Lawsuit Claims

According to a Master Case List update issued by the Northern District of Texas on June 3rd, 2013, 4,246 DePuy Pinnacle lawsuit claims had been filed in the federal proceeding. These claims were filed by patients allegedly injured by the all-metal version of the Pinnacle hip. Complications associated with this device are allegedly caused by its potential to wear out, which in turn may cause metallic debris to shed into the patient’s blood stream.

Less than a month before this Case List update was posted, Johnson & Johnson announced its plans to halt sales of the all-metal version of the DePuy Pinnacle hip replacement, as well as other metal-on-metal hip devices currently manufactured by DePuy Orthopaedics. The company’s decision to end sales of its metal-on-metal hip replacements was published in a May 16th report from the New York Times.* In citing its reasons for stopping sales of these devices, the company stressed that its decision did not signify a DePuy Pinnacle recall and was prompted by lower sales demands, as well as the U.S. Food and Drug Administration (FDA)’s recent proposal to institute new regulations for approving metal hip implants.

According to the new regulations proposed by the agency in January 2013, all manufacturers of this class of devices would be required to conduct safety and efficacy studies on their products in order to continue selling them. Thus, metal-on-metal hip replacements would become ineligible to receive approval via the FDA’s 510(k) process, which allows a device to bypass human testing.**

Patients who allegedly experienced complications stemming from the all-metal version of the DePuy Pinnacle Hip Replacement System may be entitled to compensation for medical bills, pain and suffering and other damages caused by their injuries. Visit Bernstein Liebhard LLP’s website to learn more about how to file a lawsuit over the implant you received or call a DePuy Pinnacle lawyer directly at 800-511-5092 today.

*nytimes.com/2013/05/17/business/jj-is-phasing-out-metal-replacement-hips.html?ref=health&_r=0
**fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/MetalonMetalHipImplants/ucm241604.htm

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
(877) 779-1414

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/depuy-pinnacle-lawsuit/depuy-pinnacle-recall/prweb10864866.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
2. Cell Phone Radiation Lawsuit Update: ICEMS Position Paper Supports Italian Supreme Court Ruling on Cell Phones and Brain Tumors, Bernstein Liebhard LLP Reports
3. Cell Phones and Brain Cancer: American Academy of Pediatrics Endorses Cell Phone Right to Know Act, Bernstein Liebhard LLP Reports
4. Pradaxa Side Effect Warning: Pradaxa Label to Warn Blood-Thinner Shouldn’t be Used in People with Mechanical Heart Valves, Bernstein Liebhard LLP Reports
5. New Metal-on-Metal Hip Implant Study Emphasizes Importance of Patients’ Symptoms in Evaluating the Need for Hip Replacement Revisions, Bernstein Liebhard LLP Reports
6. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
7. Propecia Lawsuits Being Investigated by Bernstein Liebhard LLP, as Propecia Litigation Pending in New Jersey Superior Court Continues to Move Forward
8. DePuy ASR Hip Recall, Transvaginal Mesh Lawsuit Updates: Bernstein Liebhard LLP Looks Forward to Start of First Bellwether Trials in New Year
9. Stryker Hip Recall Lawsuits Being Evaluated by Bernstein Liebhard LLP, Following Recall of Stryker Rejuvenate and ABG II Modular Neck Stems
10. GranuFlo Lawsuit Consolidation Supported by Fresenius Medical Care, Bernstein Liebhard LLP Reports
11. 176 Pradaxa Lawsuits Now Pending in Federal Litigation, Discovery Well Underway, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
Breaking Medicine Technology: